Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03528317 · ClinicalTrials.gov registry record · NA

Alternate Day Fasting Combined With a High Protein Background Diet

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
52
Enrollment target

NCT03528317 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 52 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03528317, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target

Study Summary

The aims of this study are as follows: AIM 1: To examine the weight loss and weight maintenance efficacy of an alternate day fasting-high protein (ADF-HP) diet; AIM 2: To examine the effects of an ADF-HP diet on metabolic disease risk factors (plasma lipids, fasting glucose, fasting insulin, insulin resistance).

Interventions

  • OTHER Alternate day fasting

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2018-06-01
Est. Completion 2019-03-01
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT03528317

The ClinicalTrials.gov registry entry for NCT03528317 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Alternate day fasting is the first listed.

NCT03528317 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03528317 about?

NCT03528317 is a clinical study titled "Alternate Day Fasting Combined With a High Protein Background Diet". The aims of this study are as follows: AIM 1: To examine the weight loss and weight maintenance efficacy of an alternate day fasting-high protein (ADF-HP) diet; AIM 2: To examine the effects of an ADF-HP diet on metabolic disease risk factors (plasma lipids, fasting glucose, fasting insulin, insulin...

What is the current status of trial NCT03528317?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2018-06-01. Estimated completion is 2019-03-01.

What interventions are being tested in trial NCT03528317?

The interventions under investigation include: Alternate day fasting (OTHER).

Who is sponsoring clinical trial NCT03528317?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.